Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
 Medical News
 Blood Safety News
 NHF and Community News
-Industry News
 Travel Advisory

 

 

 
Octapharma Announces Research Application Deadline and Launch of New Web Site
 

In October, Octapharma announced that it is accepting applications for the Octapharma 25th Anniversary Grants Program through April 1, 2011. The program supports clinical or pre-clinical research focused on human protein therapies in coagulation disorders, immunotherapy, intensive care and emergency medicine. The grants, which are available to U.S.-based researchers, are administered by Octapharma USA.

 

Octapharma AG, which manufactures plasma products, launched the grants program last year in celebration of the company’s 25th anniversary. Applications, which are only accepted online at www.octapharmagrants.com, will be evaluated by the Octapharma Grants Committee.

 

Octapharma has also launched a comprehensive new Web site related to Wilate®, the company’s plasma-derived factor replacement therapy developed for von Willebrand disease (VWD). The site provides healthcare professionals and patients with easily accessible information, news and updates. The Web site can be found at: www.wilateusa.com.

 

Sources: PR Newswire, October 4 & 14, 2010